MEDICINE & HEALTHNovavax's vaccine candidate has produced the highest number of antibodies according to vaccine experts. As they enter the final stage of human trials, they will also be testing some participants with the flu vaccine at the same time.
The FDA 'Fast Track' designation may not be as safe as people may believe, warns a medical expert. The cost the people may be paying for vaccines may be a permanent alternation in their DNA.
Moderna, the biotech company just signed a big cloud deal with Amazon Web Services that will provide its standard platform for doing analytics and machine learning as they continue to develop COVID-19 vaccines.
A recent study says that although antibodies from a previous coronavirus infection might only last a short while, protection could still be possible. Experts point out that antibodies are only a small part of the equation and that people shouldn't be discouraged from developing a vaccine for COVID-19.
Scientists from Sechenov University said they have already finished human trials for a coronavirus vaccine and results have proven the medication's effectiveness. But there are no reports yet on its commercial reproduction.
Regardless of the companies' initiative to rush in developing and testing vaccines that fight the new Coronavirus (COVID-19), the Bill and Melinda Gates Foundation, as well as the National Institutes of Health, bet that scientists, particularly the synthetic biologists, "can do even better than what's currently in the pipeline."